Cargando…
O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
Identification of novel biomarkers is helpful for the diagnosis and treatment of cervical cancer. Mucin glycosylating enzyme GALNT2 modulates mucin O-glycosylation, and has been revealed as a regulator of tumorigenesis in various cancers. However, the expression pattern of GALNT2 in cervical cancer...
Autores principales: | Zhou, Lixia, Wu, Huiqin, Bai, Xingli, Min, Shuyun, Zhang, Jiawen, Li, Cunli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469784/ https://www.ncbi.nlm.nih.gov/pubmed/36110252 http://dx.doi.org/10.3389/pore.2022.1610554 |
Ejemplares similares
-
Increased Kremen2 predicts worse prognosis in colon cancer
por: Long, Junxian, et al.
Publicado: (2023) -
APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis
por: Cao, Xiying, et al.
Publicado: (2023) -
Serum Tie-1 is a Valuable Marker for Predicting the Progression and Prognosis of Cervical Cancer
por: Bai, Rui, et al.
Publicado: (2021) -
Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation
por: Zhang, Lei, et al.
Publicado: (2023) -
SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma
por: Wang, Bingqi, et al.
Publicado: (2022)